From: Transcriptome profiling of Arabian horse blood during training regimens
N | P | Gene | N | P | Gene | N | P | Gene | |
---|---|---|---|---|---|---|---|---|---|
Training periods | T1 vs T2 | T2 vs T3 | T0 vs T3 | ||||||
transcription factors (PC00218) | 6 | ns | QKI; PPP1R37; PHTF2; MBTD1; FOXS1; ZEB2; | 34 | 0.0001 | AHR; GNPTAB; IKZF1; NCOA1; NFKBID; MBTD1; NFAT5; PDLIM5; RBBP8; RREB1 | 46 | 0.006 | NFATC1;NCOR2; FOXJ2;NFAT5;SATB1;NCOA1;SKI;QKI;AFF4 |
nucleic acid binding (PC00171) | 13 | ns | LARP4; MBTD1; WDR7; RNASE1; OAS1; FOXS1 | 42 | 0.003 | MDM4; ZBTB38; ACAP2; TOP3B; BDP1; WDR7; ATM; LARP4; SATB1 | 74 | 0.0001 | CHD2; RREB1; TRA2A; MDM4; ZBTB38; SETX; ACAP2; NCOR2; WDR7; PRRC2C; |
G-protein modulator (PC00022) | 2 | ns | P2RY14; CYSLTR1 | 10 | 0.004 | CCRL2; P2RY14; EVI5; GNB4; | 16 | 0.02 | S1PR4;P2RY14;ACAP2;APPL1 |
cytoskeletal protein (PC00085) | 28 | 0.004 | CAMK4; MYO5A; DYNC1LI2; ACTR2; LMNB2; MSN; ASPM; SEPT11; MYH9; MYO9A; SYNE3 | ||||||
actin family cytoskeletal protein (PC00041) | 15 | 0.02 | MYO5A; ACTR2; KLHL6; MSN; SPTBN1; MYO9A; ASPM; KLHL11; WASF2; SYNE3; MYH9 | ||||||
kinase (PC00137) | 3 | 0.003 | ACVR2A, MAPK3, CASK | 17 | 0.0028 | PIK3CG; EEF2K; ACVR1B; ATM; MAP3K7; ACVR2A; WNK1; HIPK3; STK17B; LRRK2; HIPK1 | 19 | 0.002 | PIK3CG; CAMK4; PANK3; MAP3K7; EEF2K; DYRK2; ATM; AURKC; HIPK3; HIPK1 |
TGF-beta receptor (PC00035) | 1 | 0.008 | ACVR2A | 1 | 0.0008 | ACVR1B; ACVR2A; | |||
defense/immunity protein (PC00090) | 5 | 0.001 | CD1C; C2; OAS1; ENSECAG00000012920; ENSECAG00000000325 | 3 | 0.001 | TXLNG; IL6ST; CCRL2; | 4 | 0.003 | TXLNA;TXLNG; NOTCH1;NOTCH2; |
cytokine receptor (PC00084) | 5 | 0.004 | ACVR2A; CD1C; ENSECAG00000012920; ENSECAG00000000325 | 4 | 0.01 | CCRL2; ACVR2A; ACVR1B; IL6ST | |||
hydrolase (PC00121) | 5 | 0.002 | RNASE1; C2; WDR7; MX1; CHI3L1; | 8 | 0.01 | EVI5; ATP11C; NUDT17; ATP13A3; TPP1; GLS; PADI6; GNB4; |